DFAT: Dimensional's Targeted Value ETF Doesn't Stack Up Against AVUV

The Dimensional U.S. Targeted Value ETF (DFAT) is downgraded to hold because it trades at 13.73x trailing-twelve-month earnings, a 15% premium to AVUV without an offsetting growth or quality advantage. The analysis says AVUV has better margins and capital efficiency despite holding smaller, presumably less-profitable companies.

Analysis

The actionable signal is relative, not an outright call on small-cap value: if DFAT’s valuation premium is not matched by stronger earnings durability, the pair’s return driver is multiple convergence plus any quality-led earnings gap. But ETF-level valuation and profitability comparisons can be distorted by sector weights, rebalancing dates, and a handful of large holdings; verify current holdings and methodology before treating the reported premium as persistent. Near term, factor flows or a small-cap/value rally could lift both funds and overwhelm the spread. Over 1–3 months, compare holdings-based forward earnings revisions and profitability, not just trailing P/E. Over 6–18 months, the thesis depends on whether AVUV’s portfolio-level quality advantage translates into better realized returns through a full earnings cycle. The contrarian risk is that DFAT’s premium reflects different exposures rather than mispricing, while AVUV’s smaller, less-profitable constituents may suffer more if financing conditions tighten. A broad small-cap rebound could also compress the relative spread without validating either fund’s security-selection edge. No independent performance, holdings, or valuation-methodology data is provided, so this is a conditional relative-value idea rather than a high-conviction outright short.

Key Decisions for Investors

• Watchlist a market-neutral DFAT-underweight/AVUV-overweight pair rather than shorting DFAT outright; initiate only after confirming comparable sector exposures and that the valuation gap persists on a consistent, holdings-weighted basis.
• Set a 1–3 month review trigger around relative earnings revisions and portfolio profitability: abandon the pair if DFAT’s holdings show materially stronger revisions or the valuation premium closes without AVUV outperforming.
• Avoid treating IWN as an automatic substitute or hedge; compare its sector and profitability profile with both funds before using it to isolate small-cap beta.
• Falsify the thesis if a broad small-cap/value rally consistently leaves DFAT outperforming AVUV, or if updated holdings data removes the reported valuation premium.